Allurion Technologies Inc. focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon) and offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite. The company is headquartered in Natick, Massachusetts.
Employees - 501,
CEO - Dr. Shantanu K. Gaur M.D.,
Sector - Healthcare,
Country - US,
Market Cap - 28.04M
Altman ZScore(max is 10): -5.86, Piotroski Score(max is 10): 1, Working Capital: $25585000, Total Assets: $50699000, Retained Earnings: $-218379000, EBIT: -18871000, Total Liabilities: $115489000, Revenue: $34753999
- Current Price $0.35 - Analyst Target Price $1.83| Ticker | ALUR |
| Index | - |
| Curent Price | 0.35 |
| Change | 24.33% |
| Market Cap | 28.04M |
| Average Volume | 408.18K |
| Income | -24.76M |
| Sales | 34.75M |
| Book Value/Share | -1.01 |
| Cash/Share | 0.36 |
| Dividend Est | - |
| Dividend TTM | - |
| Dividend Ex-Date | - |
| Employees | 252 |
| Moving Avg 20days | -3.25% |
| Moving Avg 50days | -35.06% |
| Moving Avg 200days | -70.06% |
| Shares Outstanding | 64.37M |
| Earnings Date | Nov 13 BMO |
| Inst. Ownership | 23.57% |
| Price/Earnings | - |
| Forwad P/E | - |
| PE Growth | - |
| Price/Sales | 0.81 |
| Price/Book | - |
| Price/Cash | 0.98 |
| Price/FCF | - |
| Quick Ratio | 2.09 |
| Current Ratio | 2.33 |
| Debt/Equity | - |
| Return on Assets | -28.89% |
| Return on Equity | -1715.20% |
| Return on Investment | - |
| Gross Margin | 71.80% |
| Ops Margin | -168.66% |
| Profit Margin | -71.24% |
| RSI | 41.16 |
| BETA(β) | -0.55 |
| From 52week Low | 33.85% |
| From 52week High | -91.30% |
| EPS | -0.48 |
| EPS next Year | -0.35 |
| EPS next Qtr | -0.22 |
| EPS this Year | 82.36% |
| EPS next 5 Year | - |
| EPS past 5 Year | - |
| Sales past 5 Year | -5.58% |
| EPS Y/Y | 87.95% |
| Sales Y/Y | 11.53% |
| EPS Q/Q | 74.11% |
| Sales Q/Q | -70.51% |
| Sales Surprise | -37.23% |
| EPS Surprise | 23.29% |
| ATR(14) | 0.06 |
| Perf Week | 0.69% |
| Perf Month | -23.98% |
| Perf Quarter | -44.36% |
| Perf Year | -89.64% |
| Perf YTD | -90.70% |
| Target Price | 1.83 |
AryaFin Engine© - An AI FinTech Venture - 2024 Disclaimer